Keyphrases
Immunosuppression
100%
Radiation Therapy
100%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
100%
Poor Survival
100%
Cardiac Dose
100%
Hazard Ratio
62%
Overall Survival
62%
Absolute Lymphocyte Count
37%
Multivariable
25%
Cardiac Toxicity
25%
Post-irradiation
25%
Therapy-related
25%
Heart Dose
25%
Absolute Neutrophil Count
25%
Non-associated
12%
Male Gender
12%
Patient Outcomes
12%
Chemotherapy
12%
Survivors
12%
Distant Metastasis
12%
Treatment Outcome
12%
Clinical Factors
12%
Hematotoxicity
12%
Median Survival
12%
Local Recurrence
12%
Stage III Disease
12%
Non-small Cell Lung Cancer Patients
12%
Increased Mortality
12%
Concurrent Chemoradiation
12%
Pre-radiation
12%
Vascular Density
12%
Lung Cancer Treatment
12%
Definitive Radiotherapy
12%
Neutrophil-to-lymphocyte Ratio
12%
Hematologic Variables
12%
Medicine and Dentistry
Immunosuppressive Treatment
100%
Non Small Cell Lung Cancer
100%
Radiation Therapy
100%
Hazard Ratio
55%
Overall Survival
55%
Lymphocyte
44%
Cardiotoxicity
22%
Absolute Neutrophil Count
22%
Cancer Therapy
11%
Distant Metastasis
11%
Recurrent Disease
11%
Chemoradiotherapy
11%
Pralidoxime Mesilate
11%
Diseases
11%
Neutrophil
11%
Pharmacology, Toxicology and Pharmaceutical Science
Overall Survival
100%
Non Small Cell Lung Cancer
100%
Cardiotoxicity
40%
Chemoradiation Therapy
20%
Chemotherapy
20%
Distant Metastasis
20%
Recurrent Disease
20%
Pralidoxime Mesilate
20%
Diseases
20%